Sabin polio virus protein 1 (VP1) evolution in patients with acute flaccid paralysis from 2010 to 2016 in Uganda

• Published in: Virology journal Vol. 20; no. 1; p. 172
• Main Authors: Nanteza, Mary Bridget, Bakamutumaho, Barnabas, Tushabe, Phionah, Namuwulya, Prossy, Birungi, Molly, Dhatemwa, Rajab, Eliku, James Peter, Tibanagwa, Mayi, Kakooza, Proscovia, Bukenya, Henry, Bwogi, Josephine, Byabamazima, Charles Rutebarika
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 02.08.2023; BioMed Central; BMC
• Subjects: Acute flaccid paralysis; alpha-Fetoproteins; Causes of; Cell culture; Complications and side effects; Development and progression; Diagnosis; Distribution; Enterovirus; Enzymes; Ethylenediaminetetraacetic acid; Evolution; Genetic aspects; Genomes; Humans; Identification and classification; Mutation; Outbreaks; Paralysis; Pathogenesis; Patients; Poliomyelitis; Poliomyelitis - epidemiology; Poliomyelitis - prevention & control; Poliomyelitis vaccine; Poliovirus; Poliovirus - genetics; Poliovirus Vaccine, Oral - adverse effects; Proteins; RNA polymerase; Sabin poliovirus; Uganda; Uganda - epidemiology; Vaccine-derived polioviruses; Vaccines; Viruses; VP1; VP1 protein; Uganda; Uganda; Sabin poliovirus; Vaccine-derived polioviruses; Mutation; Acute flaccid paralysis; VP1
• ISSN: 1743-422X; 1743-422X
• DOI: 10.1186/s12985-023-02143-7

Acute flaccid paralysis (AFP) is a rare side effect of the oral polio vaccine but can be associated with outbreaks and permanent disability in patients harboring circulating vaccine-derived polioviruses (cVDPVs). With the advancement of polio abolition in a glimpse, cVDPVs are causing outbreaks and slowing the polio eradication process. The polio virus protein 1 (VP1) contains the binding site that is key for virus transmission. Understanding the evolution of VP1 among AFP patients could yield more insight into the early events of cVDPVs. Polioviruses were identified from stool specimens of AFP patients using cell culture; and confirmed by the real time RT PCR intra-typic differentiation and vaccine-derived poliovirus assays. Seventy-nine (79) Sabin-like poliovirus 1 (SL1) and 86 Sabin-like poliovirus 3 (SL3) were sequenced. The VP1 amino acid substitutions T106A in Sabin poliovirus 1 and A54V in Sabin poliovirus 3 were common among the AFP patients as has been found in previous studies. Other substitutions that were associated with AFP were: T290A and A54T in SL1 and SL3 respectively. Nucleotide mutations that were common among the AFP patients included T402C, C670A, and T816C in SL1, and G22A, C375Y, A472R, and A694T in SL3 polioviruses. Characterizing mutations that are associated with AFP could contribute to efforts pursued to mitigate the risk of vaccine-derived polioviruses and promote development of safer vaccines.